Allen L G, Kalra S P
Endocrinology. 1986 Jun;118(6):2375-81. doi: 10.1210/endo-118-6-2375.
We have assessed the effects on LH release of prolonged naloxone (NAL) treatment before the critical period on proestrus. When LH secretion was monitored at 5-min intervals immediately after the start of continuous NAL infusion (2 mg/0.6 ml saline X h iv) at 1000 h, two types of responses were observed. In three of six rats, a small increase (1-2 ng rat LHRH-2/ml) during the first hour was followed by a sharp rise to 4-5 ng/ml in the second hour and a gradual return to baseline levels (0.5-1.00 ng/ml) in the third hour of infusion. In the remaining rats, LH responses were small with peak levels reaching 2 ng/ml range. When the effects were monitored 1 h after starting NAL infusion at 1000 h, the LH response was improved. Peak LH levels observed shortly before or after 1200 h varied between 4-14 ng/ml and in some rats the levels were comparable to those seen normally in the afternoon of proestrus (9-24 ng/ml). However, delaying the start of NAL infusion to 1200 h produced LH surges before 1400 h, with peak levels (27.5 +/- 5.5 ng/ml) in the range of normal preovulatory LH surges (peak levels 16.6 +/- 2.5 ng/ml), followed by a steady decrease in LH secretion. Additionally, sc NAL pellets implanted at 0930 h provoked premature LH hypersecretion with a temporal pattern (0930-1430 h) and magnitude (peak levels, 26.3 +/- 4.3 ng/ml between 1100-1200 h) comparable to the normal preovulatory LH surge observed after 1330 h. Since NAL is believed to antagonize the inhibitory effects of endogenous opioids on LH secretion, the results of this study imply that a sustained restraint on this inhibitory opioid tone can elicit the LH surge before the critical period on proestrus. These findings are in accord with our thesis that the neural clock that normally triggers the preovulatory LH surge may transiently decrease the inhibitory opioid tone to allow expression of crucial neural events which culminate in preovulatory LH secretion.
我们评估了在发情前期关键期之前长时间给予纳洛酮(NAL)治疗对促黄体生成素(LH)释放的影响。当在1000 h开始持续静脉输注NAL(2 mg/0.6 ml生理盐水×小时)后立即每隔5分钟监测一次LH分泌时,观察到两种类型的反应。在6只大鼠中的3只,最初1小时内有小幅升高(1 - 2 ng大鼠促性腺激素释放激素 - 2/ml),随后在第2小时急剧上升至4 - 5 ng/ml,并在输注的第3小时逐渐恢复到基线水平(0.5 - 1.00 ng/ml)。在其余大鼠中,LH反应较小,峰值水平达到2 ng/ml范围。当在1000 h开始NAL输注1小时后监测其效果时,LH反应有所改善。在1200 h之前或之后不久观察到的LH峰值水平在4 - 14 ng/ml之间变化,并且在一些大鼠中,这些水平与发情前期下午正常观察到的水平(9 - 24 ng/ml)相当。然而,将NAL输注开始时间推迟到1200 h会在1400 h之前引发LH激增,峰值水平(27.5±5.5 ng/ml)在正常排卵前LH激增范围内(峰值水平16.6±2.5 ng/ml),随后LH分泌稳步下降。此外,在0930 h皮下植入的NAL丸剂引发了过早的LH分泌亢进,其时间模式(0930 - 1430 h)和幅度(峰值水平,1100 - 1200 h之间为26.3±4.3 ng/ml)与1330 h后观察到的正常排卵前LH激增相当。由于认为NAL可拮抗内源性阿片类物质对LH分泌的抑制作用,本研究结果表明,对这种抑制性阿片类物质张力的持续抑制可在发情前期关键期之前引发LH激增。这些发现与我们的论点一致,即通常触发排卵前LH激增的神经时钟可能会短暂降低抑制性阿片类物质张力,以允许关键神经事件的表达,这些事件最终导致排卵前LH分泌。